A 71-year-old woman blinded by an inherited disease received a “bionic eye” from doctors at the Medical Center, allowing her to distinguish light and motion, which she hasn’t been able to do in decades.

UR Medicine’s Wilmot Cancer Institute will be among the first sites in the world to offer CAR T-cell therapy —a new type of immunotherapy approved this week by the FDA—to adults with aggressive lymphoma. The engineered gene therapy has been described as a revolutionary “living drug” and one of the most powerful cancer treatments to emerge in recent years.

The philanthropist has pledged $5 million to support construction of a new critically-needed home base treating children with depression, anxiety, PTSD, and other behavioral and emotional conditions.

Medical Center researchers are reaching for new tools, such as algorithms, machine learning, computer simulations, and mobile technologies, to both improve care and identify new therapies for complex, multi-system diseases like Parkinson’s.

Teenagers whose classes begin before 8:30 a.m. may be at particular risk, according to a recent Medical Center study that is one of the first to look specifically at school start times and compromised sleep quality.

New research will seek to understand why people who are HIV-positive are more susceptible to a progressive cerebrovascular disease that can ultimately give rise to dementia.

Rochester is participating in the largest long-term study of brain development and child health, following the biological and behavioral development of more than 10,000 children from ages 9-10 through early adulthood.

A $3.2 million grant from the National Institute on Aging brings together scientists from the Medical Center and engineers from the River Campus to develop a detailed understanding of the brain’s waste removal system.